selected scholarly activity
-
chapters
- Placebos. 725-735. 2014
-
conferences
- Software Architecture for Automated Assessment of Prescription Writing. Assistive Technology Research Series. 780-784. 2022
- Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants compared to warfarin in routine practice: interim results from a multi-centre all-comer cohort. European Heart Journal. 1008-1008. 2016
- Characteristics and reversal strategies of real-world anticoagulation-related hemorrhage in the non-vitamin K antagonist oral anticoagulant era: preliminary data from a multicentre chart review. Journal of Thrombosis and Haemostasis. 171-171. 2015
- Potential for Selection Bias in the Context of a Restriction Drug Access Program: The Case of Atomoxetine in Quebec, Canada. Pharmacoepidemiology and Drug Safety. 381-381. 2013
- Prescribing Pattern of Novel Oral Anticoagulants Following Regulatory Approval for Atrial Fibrillation in Ontario, Canada. Canadian Journal of Cardiology. S318-S319. 2013
- Systematic review of cost-effectiveness analyses of dabigatran versus warfarin for atrial fibrillation across different health care systems. Value in Health. A288-A288. 2013
- Methodologic Issues in Health Informatics Trials: The Complexities of Complex Interventions. Journal of the American Medical Informatics Association : JAMIA. 575-580. 2008
- An exploration of methodologies to individualize and integrate warfarin's benefit and harm. Pharmacoepidemiology and Drug Safety. S134-S134. 2008
- Evaluation of pharmacoepidemiology trials: Rigour methodologica versus rigor mortis. Pharmacoepidemiology and Drug Safety. S81-S81. 2008
- PCV12 METHODS FOR INDIVIDUALIZING THE BENEFIT AND HARM OF WARFARIN. Value in Health. A189-A189. 2008
- Unexpected harmful side effects triggered by immune modulation.. Blood. 80B-80B. 2006
- Are brand-name and generic warfarin interchangeable?. Clinical Pharmacology and Therapeutics. P27-P27. 2004
- Employing a validated assessment tool to evaluate interactions of warfarin with drugs and food.. Clinical Pharmacology and Therapeutics. P23-P23. 2002
- Nebulized isotonic saline: An active placebo in asthma?. Clinical Pharmacology and Therapeutics. P35-P35. 2001
- Comparison of diagnostic codes in a clinical-research database and an administrative database. Journal of the American Medical Informatics Association : JAMIA. 1045-1045. 2000
- Rational design of a computer-based decision support system for primary care settings. Journal of the American Medical Informatics Association : JAMIA. 1059-1059. 2000
- Communicating privacy and confidentiality issues to physicians and patients in a research study using electronic medical records.. Journal of the American Medical Informatics Association : JAMIA. 1098-1098. 1999
- Evidence-based EMR software selection: The complete study. TOWARD AN ELECTRONIC PATIENT RECORD '98 CONFERENCE AND EXPOSITION, PROCEEDINGS - VOLS 1-3. B51-B54. 1998
- Of rate and rhythm control in 3903 patients with atrial fibrillation. Circulation. 2973-2973. 1996
- WARFARIN AND ITS DRUG FOOD INTERACTIONS - A CRITICAL-APPRAISAL OF THE LITERATURE. Thrombosis and Haemostasis. 1133-1133. 1993
- EVIDENCE-BASED APPROACH TO DRUG-INTERACTIONS (DI) IN ANESTHESIA PRACTICE - CARDIOVASCULAR (CV) DRUGS. Anesthesia and Analgesia. S246-S246. 1993
- INTERNATIONAL PHARMACEUTICAL SURVEILLANCE - A COMMUNITY-BASED STUDY IN MEXICO. Clinical Pharmacology and Therapeutics. 148-148. 1990
-
journal articles
- Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta‐analysis. Journal of The American Geriatrics Society. 72:2552-2565. 2024
- Hydroxychloroquine-Chloroquine, QT-Prolongation, and Major Adverse Cardiac Events: A Meta-analysis and Scoping Review. Annals of Pharmacotherapy. 58:742-755. 2024
- Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trial. BMJ Open. 14:e079353-e079353. 2024
- Improving medication prescribing-related outcomes for vulnerable elderly in transitions on high-risk medications (IMPROVE-IT HRM): a pilot randomized trial protocol. Pilot and Feasibility Studies. 10:60. 2024
- Developing a reporting item checklist for studies of HIV drug resistance prevalence or incidence: a mixed methods study. BMJ Open. 14:e080014-e080014. 2024
- Characteristics of Drug Poisonings Seen in the Emergency Department of an Urban Hospital. Canadian Journal of Hospital Pharmacy. 77:e3454. 2024
- Comparability of Objective Structured Clinical Examinations (OSCEs) and Written Tests for Assessing Medical School Students’ Competencies: A Scoping Review. Evaluation and the Health Professions. 46:213-224. 2023
- Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy. Pilot and Feasibility Studies. 9:84. 2023
- Depression, anxiety and adjustment disorder among patients with psoriasis receiving systemic agents: A retrospective cohort study in Quebec, Canada. JEADV Clinical Practice. 2:38-51. 2023
- Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial. Pilot and Feasibility Studies. 8:166. 2022
- Trajectories of systemic agent use and associated depression- and anxiety-related health care costs among patients with psoriasis. JAAD Int. 9:11-22. 2022
- The impact of OHIP+ pharmacare on use and costs of public drug plans among children and youth in Ontario: a time-series analysis. CMAJ open. 10:E848-E855. 2022
- Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants. Medicina (Lithuania). 58:1171-1171. 2022
- Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials. Intensive Care Medicine. 48:811-840. 2022
- Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study. BMJ Open. 12:e057991-e057991. 2022
- A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases. Pharmacoepidemiology and Drug Safety. 31:424-433. 2022
- Variability in prescription medication coverage for children and youth across Canada: A scoping review. Health Policy. 126:269-279. 2022
- Factors that influence community hospital involvement in clinical trials: A qualitative descriptive study. Journal of Evaluation in Clinical Practice. 28:79-85. 2022
- Potentially Inappropriate Prescribing in Hospitalized Older Adult High-Cost Health Care Users: A Pilot Study. Canadian Journal of Hospital Pharmacy. 75:219-224. 2022
- Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, Canada. Frontiers in Pharmacology. 13:810309. 2022
- Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact. Systematic Reviews. 10:11. 2021
- Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial. Trials. 22:746. 2021
- Drug–drug interactions with warfarin: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 87:4051-4100. 2021
- Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home. Thrombosis Research. 206:18-28. 2021
- Sex differences in factors associated with switch between systemic agents among individuals with psoriasis: A retrospective cohort study in Quebec, Canada. JAAD Int. 4:79-83. 2021
- In healthy older adults, daily aspirin increased cancer mortality. ACP journal club. 174:JC74-JC74. 2021
- Are the correct outcomes being measured in studies of oral anticoagulants? A systematic survey. Thrombosis Research. 201:30-49. 2021
- Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study. CMAJ open. 9:E364-E375. 2021
- Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E304-E309. 2021
- Deprescribing fall-risk increasing drugs (FRIDs) for the prevention of falls and fall-related complications: a systematic review and meta-analysis. BMJ Open. 11:e035978-e035978. 2021
- Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers. PLoS ONE. 16:e0257798-e0257798. 2021
- Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health‐care providers. Journal of Thrombosis and Haemostasis. 19:153-160. 2021
- Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study. CMAJ open. 9:E44-E52. 2021
- USPSTF recommends asking adults screening questions about unhealthy drug use. ACP journal club. 173:JC38-JC38. 2020
- Barriers and facilitators to optimal oral anticoagulant management: a scoping review. Journal of Thrombosis and Thrombolysis. 50:697-714. 2020
- How personalized are benefit and harm results of randomized trials? A systematic review. Journal of Clinical Epidemiology. 126:17-25. 2020
- Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol. BMJ Open. 10:e036537-e036537. 2020
- A Systematic Review of Methods Used for Confounding Adjustment in Observational Economic Evaluations in Cardiology Conducted between 2013 and 2017. Medical decision making. 40:582-595. 2020
- Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study. Journal of Population Therapeutics and Clinical Pharmacology. 27:e32-e55. 2020
- Variation in the prescription drugs covered by health systems across high-income countries: A review of and recommendations for the academic literature. Health Policy. 124:231-238. 2020
- Oral fluoroquinolone was linked to mitral and aortic regurgitation compared with amoxicillin or azithromycin. ACP journal club. 172:JC10-JC10. 2020
- Evaluation of online clinical pharmacology curriculum resources for medical students. British Journal of Clinical Pharmacology. 85:2599-2604. 2019
- Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding. Thrombosis Research. 182:12-19. 2019
- Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study. BMJ Open. 9:e028637-e028637. 2019
- Unplanned index hospital admissions among new older high-cost health care users in Ontario: a population-based matched cohort study. CMAJ open. 7:E537-E545. 2019
- Pooled RCTs: Lowering LDL-C levels using statins reduces major vascular events in all age groups. ACP journal club. 170:JC65-JC65. 2019
- A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation. Blood Advances. 3:1638-1646. 2019
- Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis. Blood Advances. 3:789-796. 2019
- Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. European Journal of Epidemiology (EJE). 34:173-190. 2019
- Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis. Blood Advances. 3:158-167. 2019
- Evaluation of a Novel Audit Tool for Medication Reconciliation at Hospital Discharge. Canadian Journal of Hospital Pharmacy. 72:421-427. 2019
- De-prescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines. Polskie Archiwum Medycyny Wewnetrznej. 129:43-49. 2018
- GeriMedRisk, a telemedicine geriatric pharmacology consultation service to address adverse drug events in long-term care: a stepped-wedge cluster randomized feasibility trial protocol (ISRCTN17219647). Pilot and Feasibility Studies. 4:116. 2018
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Advances. 2:3257-3291. 2018
- Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study. BMC Geriatrics. 18:262-262. 2018
- Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis. CMAJ open. 6:E544-E550. 2018
- Does Googling lead to statin intolerance?. International Journal of Cardiology. 262:25-27. 2018
- Depresciption of Benzodiazepine agonists Evidence-based Clinical practice Guidelines. Canadian Family Physician. 64:E209-E224. 2018
- Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.. Canadian Family Physician. 64:339-351. 2018
- Managing High‐Cost Healthcare Users: The International Search for Effective Evidence‐Supported Strategies. Journal of The American Geriatrics Society. 66:1002-1008. 2018
- [Not Available].. Canadian Family Physician. 64:e209-e224. 2018
- Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis. Journal of Thrombosis and Thrombolysis. 45:325-336. 2018
- Review: Multilevel and patient-level implementation strategies reduce BP more than usual care in hypertension. ACP journal club. 168:JC29-JC29. 2018
- In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms. ACP journal club. 168:JC23-JC23. 2018
- PRESCRIBING COMPETENCY OF MEDICAL STUDENTS: NATIONAL SURVEY OF MEDICAL EDUCATION LEADERS. Journal of Population Therapeutics and Clinical Pharmacology. 25:e18-e24. 2018
- The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey. CMAJ open. 6:E63-E70. 2018
- Senior high-cost healthcare users’ resource utilization and outcomes: a protocol of a retrospective matched cohort study in Canada. BMJ Open. 7:e018488-e018488. 2017
- The efficacy of fall-risk-increasing drug (FRID) withdrawal for the prevention of falls and fall-related complications: protocol for a systematic review and meta-analysis. Systematic Reviews. 6:33. 2017
- Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application. Social Science and Medicine. 194:51-59. 2017
- Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?. British Journal of Clinical Pharmacology. 83:2549-2556. 2017
- Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding. Chest. 152:81-91. 2017
- Does the Number of Pharmacies a Patient Frequents Affect Adherence to Statins?. Journal of Population Therapeutics and Clinical Pharmacology. 24:e20-e50. 2017
- What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review. Journal of Population Therapeutics and Clinical Pharmacology. 24:e1-e20. 2017
- In patients receiving palliative care, risperidone or haloperidol increased delirium symptoms vs placebo. ACP journal club. 166:JC32-JC32. 2017
- Process mapping evaluation of medication reconciliation in academic teaching hospitals: a critical step in quality improvement. BMJ Open. 6:e013663-e013663. 2016
- Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis. Annals of Intensive Care. 6:18. 2016
- Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol. BMJ Open. 6:e013263-e013263. 2016
- Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation. Thrombosis Research. 145:143-148. 2016
- Use of decision aids for shared decision making in venous thromboembolism: A systematic review. Thrombosis Research. 143:71-75. 2016
- Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials. European Journal of Epidemiology (EJE). 31:541-561. 2016
- Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case. PLoS ONE. 11:e0160713-e0160713. 2016
- Management of Hospital Formularies in Ontario: Challenges within a Local Health Integration Network. Canadian Journal of Hospital Pharmacy. 69:187-193. 2016
- Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol. BMJ Open. 5:e009518-e009518. 2015
- Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients. Medicine (United States). 94:e1479-e1479. 2015
- Successful reintroduction of statin therapy after statin-associated rhabdomyolysis. Journal of Clinical Lipidology. 9:594-596. 2015
- Use of long-acting, vs short-acting, opioids for chronic pain was linked to unintentional overdose. ACP journal club. 163:JC11-JC11. 2015
- Effect of green tea supplementation on blood pressure among overweight and obese adults. Journal of Hypertension. 33:243-254. 2015
- Development and Validation of the McMaster Prescribing Competency Assessment for Medical Trainees (MacPCA).. Journal of Population Therapeutics and Clinical Pharmacology. 22:e173-e178. 2015
- Integrating Clinical Decision Support into EMR and PHR: a Case Study Using Anticoagulation.. Studies in Health Technology and Informatics. 208:98-103. 2015
- Physician and patient willingness to pay for electronic cardiovascular disease management. International Journal of Medical Informatics. 83:517-528. 2014
- The effectiveness of computerized drug-lab alerts: A systematic review and meta-analysis. International Journal of Medical Informatics. 83:406-415. 2014
- Effect of green tea supplementation on blood pressure among overweight and obese adults: a protocol for a systematic review. BMJ Open. 4:e004971-e004971. 2014
- Medication-related emergency department visits and hospitalizations among older adults.. Canadian Family Physician. 60:e217-e222. 2014
- Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications.. Journal of Population Therapeutics and Clinical Pharmacology. 21:e357-e369. 2014
- Personalized benefit-harm information influences patient decisions regarding warfarin. Journal of Population Therapeutics and Clinical Pharmacology. 20. 2013
-
Anticoagulation Control with Daily Low‐Dose Vitamin
K to Reduce Clinically Adverse Outcomes and International Normalized Ratio Variability: A Systematic Review and Meta‐Analysis. Pharmacotherapy. 33:1184-1190. 2013 - Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis. CMAJ open. 1:E115-E119. 2013
- What do Canadians think about physician–pharmaceutical industry interactions?. Health Policy. 112:255-263. 2013
- Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone. American Journal of Cardiology. 112:420-423. 2013
- Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis. Journal of Thrombosis and Haemostasis. 11:491-502. 2013
- The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal. Journal of Thrombosis and Haemostasis. 11:566-567. 2013
- Rates of hemorrhage during warfarin therapy for atrial fibrillation. CANADIAN MEDICAL ASSOCIATION JOURNAL. 185:E121-E127. 2013
- Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.. Journal of Population Therapeutics and Clinical Pharmacology. 20:e229-e237. 2013
- Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation. Blood Coagulation and Fibrinolysis. 23:705-713. 2012
- Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation. JAMA Internal Medicine. 172:1687-1687. 2012
- A survey of physicians show a one-third reduction in harmful outcomes to be a clinically important difference for statin therapy. Journal of Clinical Epidemiology. 65:954-961. 2012
- Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records. Journal of the American Medical Informatics Association : JAMIA. 19:341-345. 2012
- The drug safety and effectiveness cross-disciplinary training (DSECT) program. Journal of Population Therapeutics and Clinical Pharmacology. 19:66-72. 2012
- Evidence-Based Management of Anticoagulant Therapy. Chest. 141:e152S-e184S. 2012
- A pilot study on cost-related medication nonadherence in Ontario.. Journal of Population Therapeutics and Clinical Pharmacology. 19:e239-e247. 2012
- The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. Journal of the American Medical Informatics Association : JAMIA. 19:22-30. 2012
- Comparing methods to estimate treatment effects on a continuous outcome in multicentre randomized controlled trials: A simulation study. BMC Medical Research Methodology. 11:21. 2011
- Computerized clinical decision support systems for drug prescribing and management: A decision-maker-researcher partnership systematic review. Implementation Science. 6:89. 2011
- Shared Electronic Vascular Risk Decision Support in Primary Care. JAMA Internal Medicine. 171:1736-1736. 2011
- Effect of Computer-Generated Tailored Feedback on Glycemic Control in People With Diabetes in the Community. Diabetes Care. 34:1794-1798. 2011
- Data withdrawal in randomized controlled trials: Defining the problem and proposing solutions. Contemporary Clinical Trials. 32:318-322. 2011
- Enabling medication management through health information technology (Health IT).. Evidence report/technology assessment. 1-951. 2011
- Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?. Canadian Journal of Cardiology. 27:146-151. 2011
- Views on health information sharing and privacy from primary care practices using electronic medical records. International Journal of Medical Informatics. 80:94-101. 2011
- Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion. 50:1722-1730. 2010
- Public Perceptions of Physician–Pharmaceutical Industry Interactions: A Systematic Review. Healthcare Policy. 5:69-89. 2010
- A systematic review of medication safety outcomes related to drug interaction software.. Journal of Population Therapeutics and Clinical Pharmacology. 17:e243-e255. 2010
- Features predicting the success of computerized decision support for prescribing: a systematic review of randomized controlled trials. BMC Medical Informatics and Decision Making. 9:11. 2009
- Interventions to Improve Medication Reconciliation in Primary Care. Annals of Pharmacotherapy. 43:1667-1675. 2009
- Delay of Adequate Empiric Antibiotic Therapy Is Associated with Increased Mortality among Solid-Organ Transplant Patients. American Journal of Transplantation. 9:1657-1665. 2009
- Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 181:37-44. 2009
- Review: Anticoagulation with INRs < 2 or between 3 and 5 increases risk for thromboembolic or hemorrhagic events. ACP journal club. 149:JC5-JC5. 2008
- A systematic review of medication safety and clinical outcomes related to drug interaction software.. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 1179. 2008
- Automated telephone reminder messages can assist electronic diabetes care. Journal of Telemedicine and Telecare. 14:32-36. 2008
- Optimizing the use of prescription drugs in Canada through the Common Drug Review. CANADIAN MEDICAL ASSOCIATION JOURNAL. 178:432-435. 2008
- A comprehensive appropriateness of prescribing questionnaire was validated by nominal consensus group. Journal of Clinical Epidemiology. 60:1022-1028. 2007
- Outcomes of Dosage Adjustments Used to Manage Antiretroviral Drug Interactions. Clinical Infectious Diseases. 45:933-936. 2007
- Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 176:1583-1587. 2007
- Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial. Annals of Pharmacotherapy. 40:1241-1247. 2006
- Systematic Overview of Drug Interactions with Antidepressant Medications. Canadian Journal of Psychiatry. 51:300-316. 2006
- Best practices in EMR implementation: a systematic review.. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 2006:982. 2006
- E-health interventions as complex interventions: improving the quality of methods of assessment.. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 2006:952. 2006
- The Role of Antimalarials in the Exacerbation of Psoriasis. American Journal of Clinical Dermatology. 7:249-257. 2006
- A Canadian consensus for the standardized evaluation of quality improvement interventions in type 2 diabetes. Canadian Journal of Diabetes. 29:220-229. 2005
- Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole. JAMA Internal Medicine. 165:2540-2540. 2005
- Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole—Reply. JAMA Internal Medicine. 165:2540-2540. 2005
- Dose-reducing H2 receptor antagonists in the presence of low glomerular filtration rate: a systematic review of the evidence. Nephrology Dialysis Transplantation. 20:2376-2384. 2005
- The Impact of Reference Pricing of Nonsteroidal Anti‐Inflammatory Agents on the Use and Costs of Analgesic Drugs. Health Services Research (HSR). 40:1297-1317. 2005
- Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials. Annals of Pharmacotherapy. 39:1188-1193. 2005
- Systematic Overview of Warfarin and Its Drug and Food Interactions. JAMA Internal Medicine. 165:1095-1095. 2005
- Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.. Journal of Population Therapeutics and Clinical Pharmacology. 12:e229-e239. 2005
- Can current electronic systems meet drug safety and effectiveness requirements?. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 2005:335-339. 2005
- Individualized electronic decision support and reminders can improve diabetes care in the community.. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 2005:982. 2005
- Treating insomnia. The BMJ. 329:1198-1199. 2004
- Application of data mining techniques in pharmacovigilance. British Journal of Clinical Pharmacology. 57:127-134. 2004
- Patients' consent preferences regarding the use of their health information for research purposes: a qualitative study. Journal of Health Services Research and Policy. 9:22-27. 2004
- Placebos: our most effective therapy?. Journal of Population Therapeutics and Clinical Pharmacology. 11:e39-e40. 2004
- Innovation and placebos in research: a new design of clinical trial. The Lancet. 362:2036-2037. 2003
- Applying methodology to electronic medical record selection. International Journal of Medical Informatics. 71:43-50. 2003
- Patients' consent preferences for research uses of information in electronic medical records: interview and survey data. The BMJ. 326:373-373. 2003
- What factors determine the success of clinical decision support systems?. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 2003:862. 2003
- Restricted access for PPIs not a panacea - Response. CANADIAN MEDICAL ASSOCIATION JOURNAL. 167:1102-+. 2002
- Restricted access for PPIs not a panacea.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 167:1102. 2002
- Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 167:131-136. 2002
- Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 166:1655-1662. 2002
- Rule-based computerized reminders increased ordering of preventive services in an inpatient setting. ACP journal club. 136:74-74. 2002
- Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:1011-1019. 2001
- The Role of Benzodiazepines in the Treatment of Insomnia. Journal of The American Geriatrics Society. 49:824-826. 2001
- A critical pathway for electronic medical record selection.. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 264-268. 2001
- Measuring the success of electronic medical record implementation using electronic and survey data.. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 309-313. 2001
- Treatment of primary insomnia - Reply. CANADIAN MEDICAL ASSOCIATION JOURNAL. 163:390-391. 2000
- Treatment of primary insomnia.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 163:389-391. 2000
- Users' guides to the medical literature - XXI. Using electronic health information resources in evidence-based practice. Journal of the American Medical Association (JAMA). 283:1875-1879. 2000
- Meta-analysis of benzodiazepine use in the treatment of insomnia.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 162:225-233. 2000
- The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 162:216-220. 2000
- A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism. JAMA Internal Medicine. 160:181-181. 2000
- Is there an indication for the use of barbiturate-containing analgesic agents in the treatment of pain? Guidelines for their safe use and withdrawal management. Canadian Pharmacists Association.. Journal of Population Therapeutics and Clinical Pharmacology. 7:191-197. 2000
- Dry Powder versus Intravenous and Nebulized Gentamicin in Cystic Fibrosis and Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 160:1711-1716. 1999
- Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis - A pilot study. American Journal of Respiratory and Critical Care Medicine. 160:1711-1716. 1999
- Users' Guides to the Medical Literature. Journal of the American Medical Association (JAMA). 282:771-771. 1999
- Evaluating the impact of reference-based pricing.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 161:273-274. 1999
- Diagnosis and management of acute alcohol withdrawal.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 160:675-680. 1999
- Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 160:649-655. 1999
- Risk of a New Benzodiazepine Prescription in Relation to Recent Hospitalization. Journal of The American Geriatrics Society. 47:184-188. 1999
- Therapeutic equivalence: all studies are not created equal.. Journal of Population Therapeutics and Clinical Pharmacology. 6:9-11. 1999
- 1998 clinical practice guidelines for the management of diabetes in Canada. CANADIAN MEDICAL ASSOCIATION JOURNAL. 159:S1-S29. 1998
- Moving towards an electronic patient record: a survey to assess the needs of community family physicians.. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 230-234. 1998
- Drug interactions among commonly used medications. Chart simplifies data from critical literature review.. Canadian Family Physician. 43:1972-1981. 1997
- A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. JAMA Internal Medicine. 157:1522-1530. 1997
- Reference-based pricing (RBP) of prescription drugs.. Canadian Journal of Cardiology. 13:689-690. 1997
- The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost. Annals of Pharmacotherapy. 31:689-695. 1997
- Developing a Canadian prescribing practices network. CANADIAN MEDICAL ASSOCIATION JOURNAL. 154:1325-1331. 1996
- Developing a Canadian prescribing practices network. Network Development Committee of the Canadian Prescribing Practices Network Project.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 154:1325-1331. 1996
- Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. Journal of the American Medical Association (JAMA). 274:1800-1804. 1995
- Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence Based Medicine Working Group. Journal of the American Medical Association (JAMA). 273:1610-1613. 1995
- Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. Journal of the American Medical Association (JAMA). 272:1367-1371. 1994
- Interactions of Warfarin with Drugs and Food. ACP journal club. 121:676-676. 1994
- USERS GUIDES TO THE MEDICAL LITERATURE .5. HOW TO USE AN ARTICLE ABOUT PROGNOSIS. Journal of the American Medical Association (JAMA). 272:234-237. 1994
- Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 151:47-54. 1994
- USERS GUIDES TO THE MEDICAL LITERATURE .4. HOW TO USE AN ARTICLE ABOUT HARM. Journal of the American Medical Association (JAMA). 271:1615-1619. 1994
- Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. Journal of the American Medical Association (JAMA). 271:1615-1619. 1994
- USERS GUIDES TO THE MEDICAL LITERATURE .3. HOW TO USE AN ARTICLE ABOUT A DIAGNOSTIC-TEST .B. WHAT ARE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS. Journal of the American Medical Association (JAMA). 271:703-707. 1994
- Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. Journal of the American Medical Association (JAMA). 271:389-391. 1994
- Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. Journal of the American Medical Association (JAMA). 271:59-63. 1994
- PHARMACOKINETICS OF CARBETOCIN, A LONG-ACTING OXYTOCIN ANALOG, IN NONPREGNANT WOMEN. Current Therapeutic Research - Clinical and Experimental. 47:528-540. 1990